Cargando…

Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis

BACKGROUND: Seizures are recognised in multiple sclerosis (MS), but their true incidence and the mechanism by which they are associated with MS is unclear. OBJECTIVE: The objective of this paper is to determine the lifetime frequency of seizures in the United Kingdom MS Tissue Bank (UKMSTB) populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicholas, Richard, Magliozzi, Roberta, Campbell, Graham, Mahad, Don, Reynolds, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702245/
https://www.ncbi.nlm.nih.gov/pubmed/25921040
http://dx.doi.org/10.1177/1352458515579445
_version_ 1782408607390760960
author Nicholas, Richard
Magliozzi, Roberta
Campbell, Graham
Mahad, Don
Reynolds, Richard
author_facet Nicholas, Richard
Magliozzi, Roberta
Campbell, Graham
Mahad, Don
Reynolds, Richard
author_sort Nicholas, Richard
collection PubMed
description BACKGROUND: Seizures are recognised in multiple sclerosis (MS), but their true incidence and the mechanism by which they are associated with MS is unclear. OBJECTIVE: The objective of this paper is to determine the lifetime frequency of seizures in the United Kingdom MS Tissue Bank (UKMSTB) population and any pathological features associated with seizures. METHODS: We evaluated 255 individuals from the UKMSTB. A subset underwent analysis of cortical thickness, grey matter lesion (GML) (type and number) and cortical neuronal numbers (total and GABAergic). RESULTS: A total of 37/255 patients had seizures (14.5% lifetime incidence); in 47% they were associated with concurrent infection. In those with seizures, death and wheelchair use occurred earlier and in 59% seizures developed after 15 years of disease. Seizures were associated with Type 1 GMLs and reduced cortical thickness in the middle temporal gyrus. Localised selective GABAergic interneuron loss in layers IV and VI was related to GMLs but was not explained by the presence of inflammation or by mitochondrial dysfunction within Type I GMLs. CONCLUSION: We confirm that seizure frequency rises in MS. Type I GMLs in the temporal lobe underlie a loss of inhibitory interneurons in cortical layers IV and VI and these changes could together with concurrent infection enhance susceptibility to seizures.
format Online
Article
Text
id pubmed-4702245
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-47022452016-01-25 Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis Nicholas, Richard Magliozzi, Roberta Campbell, Graham Mahad, Don Reynolds, Richard Mult Scler Original Research Papers BACKGROUND: Seizures are recognised in multiple sclerosis (MS), but their true incidence and the mechanism by which they are associated with MS is unclear. OBJECTIVE: The objective of this paper is to determine the lifetime frequency of seizures in the United Kingdom MS Tissue Bank (UKMSTB) population and any pathological features associated with seizures. METHODS: We evaluated 255 individuals from the UKMSTB. A subset underwent analysis of cortical thickness, grey matter lesion (GML) (type and number) and cortical neuronal numbers (total and GABAergic). RESULTS: A total of 37/255 patients had seizures (14.5% lifetime incidence); in 47% they were associated with concurrent infection. In those with seizures, death and wheelchair use occurred earlier and in 59% seizures developed after 15 years of disease. Seizures were associated with Type 1 GMLs and reduced cortical thickness in the middle temporal gyrus. Localised selective GABAergic interneuron loss in layers IV and VI was related to GMLs but was not explained by the presence of inflammation or by mitochondrial dysfunction within Type I GMLs. CONCLUSION: We confirm that seizure frequency rises in MS. Type I GMLs in the temporal lobe underlie a loss of inhibitory interneurons in cortical layers IV and VI and these changes could together with concurrent infection enhance susceptibility to seizures. SAGE Publications 2016-01 /pmc/articles/PMC4702245/ /pubmed/25921040 http://dx.doi.org/10.1177/1352458515579445 Text en © The Author(s), 2015 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Papers
Nicholas, Richard
Magliozzi, Roberta
Campbell, Graham
Mahad, Don
Reynolds, Richard
Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis
title Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis
title_full Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis
title_fullStr Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis
title_full_unstemmed Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis
title_short Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis
title_sort temporal lobe cortical pathology and inhibitory gaba interneuron cell loss are associated with seizures in multiple sclerosis
topic Original Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702245/
https://www.ncbi.nlm.nih.gov/pubmed/25921040
http://dx.doi.org/10.1177/1352458515579445
work_keys_str_mv AT nicholasrichard temporallobecorticalpathologyandinhibitorygabainterneuroncelllossareassociatedwithseizuresinmultiplesclerosis
AT magliozziroberta temporallobecorticalpathologyandinhibitorygabainterneuroncelllossareassociatedwithseizuresinmultiplesclerosis
AT campbellgraham temporallobecorticalpathologyandinhibitorygabainterneuroncelllossareassociatedwithseizuresinmultiplesclerosis
AT mahaddon temporallobecorticalpathologyandinhibitorygabainterneuroncelllossareassociatedwithseizuresinmultiplesclerosis
AT reynoldsrichard temporallobecorticalpathologyandinhibitorygabainterneuroncelllossareassociatedwithseizuresinmultiplesclerosis